Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.64 |
| ▸ | CTSL | P07711 | 1/20 | 0.61 |
| ▸ | CTSB | P07858 | 1/20 | 0.61 |
| ▸ | CTSS | P25774 | 1/20 | 0.61 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.58 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.58 |
| ▸ | HPGDS | O60760 | 3/20 | 0.56 |
| ▸ | CNR2 | P34972 | 3/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.55 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.55 |
| ▸ | PTPRA | P18433 | 1/20 | 0.55 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.55 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.55 |
| ▸ | FCER2 | P06734 | 2/20 | 0.53 |
| ▸ | MMP1 | P03956 | 1/20 | 0.53 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.53 |
| ▸ | CHRNG | P07510 | 1/20 | 0.53 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.53 |
| ▸ | CHRND | Q07001 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3956755 | 1.00 | PTPN1 (0.64) | PTPN1CTSLCTSBCTSSPSMB8 | |
| SCHEMBL14611741 | 0.87 | CTSL (0.65) | CTSLCTSBCTSSPSMB8PSMB5 | |
| SCHEMBL1329813 | 0.87 | CTSC (0.59) | PTPN1HPGDSFCER2MMP1 | |
| SCHEMBL13649440 | 0.87 | HPGDS (0.56) | PTPN1HPGDSFCER2MMP1 | |
| SCHEMBL1329814 | 0.87 | CTSC (0.59) | PTPN1HPGDSFCER2MMP1 | |
| SCHEMBL15083422 | 0.87 | HPGDS (0.56) | PTPN1HPGDSFCER2MMP1 | |
| SCHEMBL10504767 | 0.86 | ITGB3 (0.65) | CTSLCTSBCTSSPSMB8PSMB5 | |
| SCHEMBL4144665 | 0.86 | ITGB3 (0.65) | CTSLCTSBCTSSPSMB8PSMB5 | |
| SCHEMBL4144668 | 0.86 | ITGB3 (0.65) | CTSLCTSBCTSSPSMB8PSMB5 | |
| SCHEMBL2171623 | 0.85 | PTPN1 (0.57) | PTPN1CTSLCTSBCTSSCNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1414783-B1 | METHOD FOR THE PRODUCTION OF AMINES BY REDUCTIVE AMINATION OF CARBONYL COMPOUNDS UNDER TRANSFER-HYDROGENATION CONDITIONS | EVONIK DEGUSSA GMBH (DE) | 2009-07-15 | — | — | EP | disclosed |
| US-7230134-B2 | Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions | DEGUSSA AG (DE) | 2007-06-12 | — | — | US | disclosed |
| US-7230134-B2 | Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions | DEGUSSA AG (DE) | 2007-06-12 | — | — | US | disclosed |
| US-7230134-B2 | Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions | DEGUSSA AG (DE) | 2007-06-12 | — | — | US | disclosed |
| US-20040267051-A1 | Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions | EVONIK DEGUSSA GMBH (DE) | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040267051-A1 | Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions | HNMT, AADAT, ADH5 | PTPN1 4877/4885CTSL 4461/4885CTSB 3146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.